FDA Floats Eliminating Multi-Ingredient Pediatric Cold Products
This article was originally published in The Pink Sheet Daily
Executive Summary
Consumer Healthcare Products Association, FDA agree labeling for OTC cough/cold drugs should indicate use is not safe for children under 2 years old, while Center for Drug Evaluation and Research cites “heightened risk of overdose due to concurrent therapy with multi-ingredient” products.